Tetratherix Improves Cash Position With Inaugural Superpower License Fee, Capital Raise
MT Newswires Live
Jul 22
Tetratherix (ASX:TTX) received its first license fee revenue of $3 million in the June quarter as part of an exclusive research and development agreement with US consumer health group Superpower, according to a Wednesday filing with the Australian bourse.
The fee revenue, combined with a net AU$14.7 million from a placement in May, left the company with a "strong cash position" of AU$34.4 million as of June 30, per the filing.
The company closed the March quarter with AU$19.2 million of cash on hand, a previous filing showed.
Tetratherix said it saw AU$19.3 million of cash inflows in the three months through June, bringing the total to AU$21.9 million for the full 2026 fiscal year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.